About Us
HekaBio is an asset-light emerging commercial-stage biopharma and MedTech platform for in-licensing early, de-risked assets to commercialize in Japan and the APAC region.
We conduct clinical trials, secure regulatory and pricing approvals and optimize commercial opportunities through our strong network of partners in pharma, MedTech, hospitals and the Government of Japan.
Our multicultural team has 50+ approvals in Japan and a stellar
in-licensed portfolio at an inflection point for commercial sales from Q1 2026.
Our Mission
Our mission is to accelerate patient access to world-leading healthcare solutions throughout Asia Pacific, starting with Japan
Our Core Values
Meaning of "Heka"
In Egyptian mythology, Heka is the personification of healing and magic. Heka literally means “engaging the spirit or vital force”.
Credit of photo: Esna_Tempel_13.jpg:
Olaf Tausch derivative work: Oltau, CC BY 3.0, via Wikimedia Commons